| Dr Estela Sosa, MD | |
|
590 Court St, Keene, NH 03431-1719 | |
| (603) 354-5400 | |
| Not Available |
| Full Name | Dr Estela Sosa |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 590 Court St, Keene, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356465140 | NPI | - | NPPES |
| 131247201 | Medicaid | TX | |
| 101949100 | Other | TX | VALLEY HEALTH PLANS |
| 160053362 | Other | TX | RAILROAD MEDICARE |
| 8A2660 | Other | TX | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | H5492 (Texas) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 19610 (New Hampshire) | Primary |
| Entity Name | Claremore Indian Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073527842 PECOS PAC ID: 9436069911 Enrollment ID: O20031210001104 |
News Archive
Your risk of heart attack increases with the amount of traffic noise to which you are exposed. The increase in risk - though slight - is greatest with road and rail traffic noise, less with aircraft noise.
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that the independent Data and Safety Monitoring Board (DSMB) overseeing the Company's two ongoing stem cell clinical trials in the United States authorized ACT to move forward with enrolling and treating the next set of patients in each of the trials.
Researchers discuss the preparation and characterization of EVs-ACE2, along with the production and characterization of SARS-CoV-2 S-pseudovirus.
Boston Heart Diagnostics Corporation, a pioneer in integrating next-generation diagnostics with personal nutrition and lifestyle programs for patients with or at risk for heart disease, has received $1.0 million in additional tax incentives through the Life Sciences Tax Incentive Program.
Two decades ago, the landmark Cruzan decision catalyzed individual thinking, policy discussions and lawmaking about advance care directives and choices.
› Verified 4 days ago
| Entity Name | Texas Specialty Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558521179 PECOS PAC ID: 6305901927 Enrollment ID: O20090216000230 |
News Archive
Your risk of heart attack increases with the amount of traffic noise to which you are exposed. The increase in risk - though slight - is greatest with road and rail traffic noise, less with aircraft noise.
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that the independent Data and Safety Monitoring Board (DSMB) overseeing the Company's two ongoing stem cell clinical trials in the United States authorized ACT to move forward with enrolling and treating the next set of patients in each of the trials.
Researchers discuss the preparation and characterization of EVs-ACE2, along with the production and characterization of SARS-CoV-2 S-pseudovirus.
Boston Heart Diagnostics Corporation, a pioneer in integrating next-generation diagnostics with personal nutrition and lifestyle programs for patients with or at risk for heart disease, has received $1.0 million in additional tax incentives through the Life Sciences Tax Incentive Program.
Two decades ago, the landmark Cruzan decision catalyzed individual thinking, policy discussions and lawmaking about advance care directives and choices.
› Verified 4 days ago
| Entity Name | Health And Human Services Commission |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356414692 PECOS PAC ID: 2163795824 Enrollment ID: O20170908001058 |
News Archive
Your risk of heart attack increases with the amount of traffic noise to which you are exposed. The increase in risk - though slight - is greatest with road and rail traffic noise, less with aircraft noise.
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that the independent Data and Safety Monitoring Board (DSMB) overseeing the Company's two ongoing stem cell clinical trials in the United States authorized ACT to move forward with enrolling and treating the next set of patients in each of the trials.
Researchers discuss the preparation and characterization of EVs-ACE2, along with the production and characterization of SARS-CoV-2 S-pseudovirus.
Boston Heart Diagnostics Corporation, a pioneer in integrating next-generation diagnostics with personal nutrition and lifestyle programs for patients with or at risk for heart disease, has received $1.0 million in additional tax incentives through the Life Sciences Tax Incentive Program.
Two decades ago, the landmark Cruzan decision catalyzed individual thinking, policy discussions and lawmaking about advance care directives and choices.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Estela Sosa, MD 590 Court St, Keene, NH 03431-1719 Ph: (603) 354-5400 | Dr Estela Sosa, MD 590 Court St, Keene, NH 03431-1719 Ph: (603) 354-5400 |
News Archive
Your risk of heart attack increases with the amount of traffic noise to which you are exposed. The increase in risk - though slight - is greatest with road and rail traffic noise, less with aircraft noise.
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that the independent Data and Safety Monitoring Board (DSMB) overseeing the Company's two ongoing stem cell clinical trials in the United States authorized ACT to move forward with enrolling and treating the next set of patients in each of the trials.
Researchers discuss the preparation and characterization of EVs-ACE2, along with the production and characterization of SARS-CoV-2 S-pseudovirus.
Boston Heart Diagnostics Corporation, a pioneer in integrating next-generation diagnostics with personal nutrition and lifestyle programs for patients with or at risk for heart disease, has received $1.0 million in additional tax incentives through the Life Sciences Tax Incentive Program.
Two decades ago, the landmark Cruzan decision catalyzed individual thinking, policy discussions and lawmaking about advance care directives and choices.
› Verified 4 days ago
Dr. Heidi Fedrizzi Rinehart, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 590 Court St, Keene, NH 03431 Phone: 603-354-5400 Fax: 603-354-6645 | |
Denise F Poulin, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 590 Court Street, Obstetrics & Gynecology, Keene, NH 03431 Phone: 603-354-5400 | |
Dr. Lynn Ai Nguyen, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 590 Court St, Keene, NH 03431 Phone: 603-354-6534 | |
Dr. Lisa K Stolper, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 590 Court St, Keene, NH 03431 Phone: 603-354-6640 Fax: 603-354-6645 | |
Kimberly M Devore, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 590 Court Street, Keene, NH 03431 Phone: 603-354-5400 | |
Karen Bradley, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 590 Court St, Keene, NH 03431 Phone: 603-354-5454 |